Hedge Fund - Euclidean Capital
Oric Pharmaceuticals Inc. (ORIC)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $8,093,374 | 2.19% | 989,410 | $11.51 |
| 2 | 2025 - Q3 (2025-09-30) | $11,872,920 | 4.99% | 989,410 | $10.52 |
| 3 | 2025 - Q2 (2025-06-30) | $10,042,512 | 3.28% | 989,410 | $6.71 |
| 4 | 2025 - Q1 (2025-03-31) | $5,520,908 | 2.07% | 989,410 | $8.74 |
| 5 | 2024 - Q4 (2024-12-31) | $7,984,539 | 1.08% | 989,410 | $9.18 |
| 6 | 2024 - Q3 (2024-09-30) | $10,141,453 | 1.11% | 989,410 | $9.89 |
| 7 | 2024 - Q2 (2024-06-30) | $6,995,129 | 0.87% | 989,410 | $8.95 |
| 8 | 2024 - Q1 (2024-03-31) | $13,604,388 | 1.74% | 989,410 | $11.88 |
| 9 | 2023 - Q4 (2023-12-31) | $9,102,572 | 1.02% | 989,410 | $7.23 |
| 10 | 2023 - Q3 (2023-09-30) | $5,985,931 | 1.3% | 989,410 | $8.19 |
| 11 | 2023 - Q2 (2023-06-30) | $5,800,988 | 1.49% | 747,550 | $5.68 |
| 12 | 2023 - Q1 (2023-03-31) | $4,261,035 | 3.73% | 747,550 | $5.23 |
| 13 | 2022 - Q4 (2022-12-31) | $4,403,070 | 4.11% | 747,550 | $3.38 |
| 14 | 2022 - Q3 (2022-09-30) | $2,392,000 | 2.22% | 747,550 | $4.00 |
| 15 | 2022 - Q2 (2022-06-30) | $3,349,000 | 2.84% | 747,550 | $3.99 |
| 16 | 2022 - Q1 (2022-03-31) | $3,992,000 | 2.31% | 747,550 | $9.01 |
| 17 | 2021 - Q4 (2021-12-31) | $10,989,000 | 6.24% | 747,550 | $15.59 |
| 18 | 2021 - Q3 (2021-09-30) | $16,251,000 | 7.89% | 777,193 | $20.27 |
| 19 | 2021 - Q2 (2021-06-30) | $17,632,000 | 5.72% | 996,734 | $21.91 |
| 20 | 2021 - Q1 (2021-03-31) | $24,420,000 | 8.17% | 996,734 | $31.60 |
| 21 | 2020 - Q4 (2020-12-31) | $47,405,000 | 10.03% | 1,400,435 | $28.69 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center